Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
Abstract Background There have been several reports on dasatinib-induced reversible pulmonary hypertension. This is the first reported case in Latvia; the patient did not discontinue the drug after the first adverse effects in the form of pleural effusions, which we speculate led only to partial rev...
Main Authors: | Andris Skride, Matiss Sablinskis, Kristaps Sablinskis, Krista Lesina, Aivars Lejnieks, Sandra Lejniece |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-017-1515-9 |
Similar Items
-
Pulmonary Endarterectomy in Latvia: A National Experience
by: Matiss Sablinskis, et al.
Published: (2019-01-01) -
Dasatinib-induced pleural effusion: Chylothorax, an option to consider
by: Lucia Ferreiro, et al.
Published: (2016-01-01) -
Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report
by: Gülten Taçoy, et al.
Published: (2015-01-01) -
Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01) -
Ambrisentan-induced severe asymptomatic thrombocytopenia
by: Dana Kigitovica, et al.
Published: (2020-10-01)